In Brief: Possis Medical AngioJet
This article was originally published in The Gray Sheet
Executive Summary
Possis Medical AngioJet: First patient treatment with water-propelled thrombectomy system performed at Boston's Beth Israel Hospital. The initial procedure "successfully removed blood clot and other obstructive material from a severely degenerated bypass graft," according to the firm, prior to a "planned multiple coronary stent placement." Beth Israel is one of four U.S. clinical sites approved for the Phase I study, which is expected to involve approximately 60 procedures...
You may also be interested in...
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.
Drug Shortages, Inspections In Focus At US FDA Appropriations Hearing
Commissioner Robert Califf discussed the agency’s request for $12.3m to address shortages and legislation to require that manufacturers provide more detailed information about increased demand and supply chain vulnerabilities.